Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-20-009712
Filing Date
2020-05-22
Accepted
2020-05-22 16:30:50
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 98870
2 ex31.htm EX-31 10196
3 ex32.htm EX-32 7592
  Complete submission text file 0001493152-20-009712.txt   117678
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38519 | Film No.: 20906370
SIC: 2834 Pharmaceutical Preparations